Back
Safran SA Vs. Longboard Pharmaceuticals Industry Stock Comparison
Buy
65
SAFRF
Safran SA
Last Price:
226.02
Seasonality Move:
7.43%
Buy
51
LBPH
Longboard Pharmaceuticals
Last Price:
36.10
Seasonality Move:
-17.08%
Buy
65
Safran SA (SAFRF)
is a Buy
Is Safran SA a Buy, Sell or Hold?
- The current Safran SA [SAFRF] share price is $235.50. The Score for SAFRF is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
- SAFRF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
51
Longboard Pharmaceuticals (LBPH)
is a Buy
Is Longboard Pharmaceuticals a Buy, Sell or Hold?
- The current Longboard Pharmaceuticals [LBPH] share price is $36.05. The Score for LBPH is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- LBPH is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SAFRF Stock Price Chart
LBPH Stock Price Chart
What is Longboard Pharmaceuticals's stock price today?
-
The Longboard Pharmaceuticals share price today is $36.05
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LBPH is experiencing slight selling pressure.
SAFRF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.67 | Buy |
| Relative Strength Index (14 RSI): | 61.95 | Buy |
| Chaikin Money Flow: | 929 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (216.52 - 234.7) | Buy |
| Bollinger Bands (100): | (213.83 - 229.55) | Buy |
LBPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.29 | Buy |
| Relative Strength Index (14 RSI): | 56.75 | Buy |
| Chaikin Money Flow: | -19224 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (31.32 - 35.78) | Buy |
| Bollinger Bands (100): | (22.37 - 36.89) | Buy |
SAFRF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 235.64 | Sell |
| 20-day SMA: | 228.19 | Buy |
| 50-day SMA: | 220.42 | Buy |
| 200-day SMA: | 213.04 | Buy |
| 8-day EMA: | 233.81 | Buy |
| 20-day EMA: | 229.52 | Buy |
| 50-day EMA: | 223.92 | Buy |
| 200-day EMA: | 209.86 | Buy |
LBPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 33.77 | Buy |
| 20-day SMA: | 33.19 | Buy |
| 50-day SMA: | 34.29 | Buy |
| 200-day SMA: | 24.69 | Buy |
| 8-day EMA: | 34.51 | Buy |
| 20-day EMA: | 33.78 | Buy |
| 50-day EMA: | 33.09 | Buy |
| 200-day EMA: | 25.05 | Buy |
Safran SA Earnings Growth & SAFRF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Longboard Pharmaceuticals Earnings Growth & LBPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.21 per share, and a decrease next year of $0.53 per share.
Safran SA Technical Analysis
| Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Longboard Pharmaceuticals Technical Analysis
| Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||